SCHEMBL4132539

SCHEMBL4132539

Cc1ccc(-n2c(C(F)(F)F)nc3sc4c(c3c2=O)CCCC4)cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
LMNA P02545 5/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 2/20 0.52
MAPT P10636 5/20 0.50
TP53 P04637 2/20 0.50
SMN1; SMN2 Q16637 5/20 0.48
KDM4E B2RXH2 3/20 0.48
TSHR P16473 1/20 0.48
HPGD P15428 3/20 0.47
GAA P10253 2/20 0.47
NPC1 O15118 1/20 0.47
CASP3 P42574 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
NPSR1 Q6W5P4 2/20 0.47
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4134827 0.99 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4144240 0.89 MAPT (0.62) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4144324 0.86 TP53 (0.50) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4139659 0.85 TP53 (0.49) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4132514 0.85 ALDH1A1 (0.60) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4141371 0.85 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4144919 0.85 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4134647 0.84 MAPT (0.52) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4153731 0.84 MAPT (0.52) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL4132531 0.84 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143411-A1 Thiophens and Their Use as Anti-Tumor Agents COMPASS PHARMACEUTICALS LLC (US) 2009-06-04 US claimed
US-20090143411-A1 Thiophens and Their Use as Anti-Tumor Agents COMPASS PHARMACEUTICALS LLC (US) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143411-A1 Thiophens and Their Use as Anti-Tumor Agents TP53, BRDT, VHL ALDH1A1 1202/4885LMNA 3634/4885MEN1 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.